Abeona Therapeutics Inc.
ABEO | NASDAQ
$5.82
+$0.15 (+2.65%)
Sep 22, 2026, 2:36 PM ET · Market open
Market Data
Market Cap $323.16M
Enterprise Value $196.21M
Beta 1.32
Average Volume 1.3M
Shares Outstanding (Diluted) 57.05M
Shares Change YoY -14.39%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US00289Y2063
Price Performance
Price Change 1M -7.2%
Price Change 3M -0.9%
Price Change 6M 28.3%
Price Change YTD 6.8%
Price Change 1Y 3.5%
Price Change 3Y 49.6%
Price Change 5Y -80.8%
1M CAGR (ann.) -21.7%
1Y CAGR (ann.) 0.5%
5Y CAGR (ann.) -29.3%
All-Time CAGR -23.9%
Valuation
PE Ratio -5.11
Forward PE 391.36
PEG Ratio 0.02
Forward PEG 0.06
PS Ratio 12.66
Forward PS 2.70
PB Ratio 2.52
P/FCF Ratio -3.96
P/Adj. FCF Ratio -3.57
P/OCF Ratio -4.23
EV/Sales 7.69
EV/EBIT -2.62
EV/EBITDA -2.75
EV/FCF -2.41
Earnings Yield -19.6%
FCF Yield -25.2%
Adj. FCF Yield -28.0%
Financial Health
Net Cash $131.84M
Total Debt $19.87M
Cash & Short-Term Investments $146.83M
Total Assets $179.51M
Current Ratio 6.63
Quick Ratio 6.40
Debt / Equity Ratio 0.16
Debt / EBITDA -0.28
Debt / FCF -0.24
OCF / Debt -3.85
Interest Coverage -25.25
Altman Z-Score -2.61
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 56.6%
Operating Profit Margin -327.6%
EBITDA Margin -279.9%
Net Profit Margin -246.4%
FCF Margin -319.5%
Adj. FCF Margin -354.2%
SBC / Revenue 34.8%
SBC Impact (per share) -10.9%
Returns
Return on Assets -35.0%
Return on Equity -41.7%
Return on Invested Capital -39.7%
Return on Capital Employed -54.0%
Return on Tangible Assets -35.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 92.7%
Revenue CAGR 5Y 20.6%
Revenue CAGR 10Y 39.0%
EPS CAGR 3Y 58.9%
EPS CAGR 5Y 79.2%
EPS CAGR 10Y 22.7%
FCF CAGR 3Y -28.9%
FCF CAGR 5Y -9.3%
FCF CAGR 10Y -7.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 75.2%
Revenue Growth Next 3Y 122.9%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.14
EPS Growth Est (next Q) 40.0%
Revenue Est (next Q) $16.48M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $17.67
Price Target Upside 211.6%
Cash Flow
Operating Cash Flow $-76.44M
Free Cash Flow $-81.53M
Adj. Free Cash Flow $-90.4M
FCF Per Share -$1.43
OCF Per Share -$1.34
OCF/S Ratio -299.5%
Income Statement
Revenue $25.52M
Gross Profit $14.45M
Operating Income $-83.62M
EBITDA $-71.44M
Net Income $-62.89M
EPS (Diluted) -$1.11
Revenue / Employee $112.92K
Profit / Employee $-278.26K
Employees 226
Add to Watchlist
Select watchlists to add or remove ABEO